Sex, race, age disparities in survival for HPV-linked cancer

Sex, race, age disparities in survival for HPV-linked cancer

(HealthDay)—For patients with human papillomavirus (HPV)-associated cancers, there are large disparities in survival based on sex, race, and age, according to a study published online Nov. 6 in Cancer.

Hilda Razzaghi, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined high-quality data from 27 population-based registries covering about 59 percent of the U.S. population to examine how relative survival varies for HPV-associated cancers. The analyses were limited to invasive cancers diagnosed during 2001 through 2011, and followed through 2011. Five-year relative survival was calculated from diagnosis to death.

The researchers found that the five-year age-standardized relative survival rates for cervical carcinomas, vaginal squamous cells carcinomas (SCCs), vulvar SCCs, penile SCCs, anal SCCs, rectal SCCs, and oropharyngeal SCCs were 64.2, 52.8, 66.0, 47.4, 65.9, 56.2, and 51.2 percent, respectively. Compared with black patients, white patients had consistently higher five-year relative survival for all HPV-associated cancers across all age groups, with the greatest differences by race seen for oropharyngeal SCCs among those aged <60 years and among those aged 40 to 49 years with penile SCCs.

"There are large disparities in relative survival among with HPV-associated cancers by sex, race, and age," the authors write. "HPV vaccination and improved access to screening (of cancers for which screening tests are available) and treatment, especially among groups that experience higher incidence and lower survival, may reduce disparities in survival from HPV-associated cancers."

Explore further

Study reveals large disparities in survival for patients with HPV-associated cancers

More information: Abstract
Full Text
Journal information: Cancer

Copyright © 2017 HealthDay. All rights reserved.

Citation: Sex, race, age disparities in survival for HPV-linked cancer (2017, November 28) retrieved 3 December 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments